Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Drug Resistance

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 94 articles:
HTML format



Single Articles


    October 2022
  1. ALLAN-BLITZ LT, Adamson PC, Klausner JD
    Resistance-Guided Therapy for Neisseria gonorrhoeae.
    Clin Infect Dis. 2022;75:1655-1660.
    PubMed     Abstract available


    September 2022
  2. LUTERBACH CL, Chen L, Komarow L, Ostrowsky B, et al
    Transmission of Carbapenem-resistant Klebsiella pneumoniae in US hospitals.
    Clin Infect Dis. 2022 Sep 29. pii: 6731222. doi: 10.1093.
    PubMed     Abstract available


  3. VODSTRCIL LA, Plummer EL, Doyle M, Murray GL, et al
    Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure.
    Clin Infect Dis. 2022;75:813-823.
    PubMed     Abstract available


  4. DERESINSKI S
    OXA-48, AmpC, or Both-Activity of Some Newer ss-Lactams.
    Clin Infect Dis. 2022;75:i-ii.
    PubMed    


    August 2022
  5. LAMOTH F, Lewis RE, Kontoyiannis DP
    Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective.
    Clin Infect Dis. 2022;75:534-544.
    PubMed     Abstract available


  6. ROCK C, Hsu YJ, Curless MS, Carroll KC, et al
    Ultraviolet-C Light Evaluation as Adjunct Disinfection to Remove Multidrug-Resistant Organisms.
    Clin Infect Dis. 2022;75:35-40.
    PubMed     Abstract available


  7. SIMNER PJ, Mostafa HH, Bergman Y, Ante M, et al
    Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression.
    Clin Infect Dis. 2022;75:47-54.
    PubMed     Abstract available


    July 2022
  8. GETMAN D, Cohen S, Jiang A
    Distribution of Macrolide Resistant Mycoplasma genitalium in Urogenital Tract Specimens from Women Enrolled in a US Clinical Study Cohort.
    Clin Infect Dis. 2022 Jul 23. pii: 6649231. doi: 10.1093.
    PubMed     Abstract available


  9. BAGGS J, Rose AN, McCarthy NL, Wolford H, et al
    Antibiotic Resistant Infections among COVID-19 Inpatients in U.S. Hospitals.
    Clin Infect Dis. 2022 Jul 2. pii: 6627591. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  10. HEYSELL SK, Mpagama SG, Ogarkov OB, Conaway M, et al
    Pharmacokinetic-pharmacodynamic determinants of clinical outcomes for rifampin-resistant tuberculosis: a multi-site prospective cohort study.
    Clin Infect Dis. 2022 Jun 22. pii: 6613372. doi: 10.1093.
    PubMed     Abstract available


  11. WEERDENBURG E, Davies T, Morrow B, Zomer AL, et al
    Global Distribution of O-Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli (ExPEC) Collected From the Blood of Bacteremia Patients Across Multiple Surveillance Studies.
    Clin Infect Dis. 2022 Jun 10. pii: 6605050. doi: 10.1093.
    PubMed     Abstract available


  12. ROGERS R, Krause PJ, Norris AM, Ting MH, et al
    Broad antimicrobial resistance in a case of relapsing babesiosis successfully treated with tafenoquine.
    Clin Infect Dis. 2022 Jun 10. pii: 6605069. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  13. MILLER LG, Singh R, Eells SJ, Gillen D, et al
    Chlorhexidine and Mupirocin for Clearance of Methicillin Resistant Staphylococcus aureus Colonization After Hospital Discharge: A Secondary Analysis of the CLEAR Trial.
    Clin Infect Dis. 2022 May 31. pii: 6595699. doi: 10.1093.
    PubMed     Abstract available


  14. PIDDOCK LJV, Paccaud JP, O'Brien S, Childs M, et al
    A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution.
    Clin Infect Dis. 2022;74:1866-1871.
    PubMed     Abstract available


  15. SATLIN MJ, Chen L, Gomez-Simmonds A, Marino J, et al
    Impact of a Rapid Molecular Test for Klebsiella pneumoniae Carbapenemase and Ceftazidime-Avibactam Use on Outcomes after Bacteremia Caused by Carbapenem-Resistant Enterobacterales.
    Clin Infect Dis. 2022 May 6. pii: 6581726. doi: 10.1093.
    PubMed     Abstract available


  16. YIN M
    Rapid diagnostics for antibiotic resistance: urgent need for strong clinical evidence.
    Clin Infect Dis. 2022 May 4. pii: 6580089. doi: 10.1093.
    PubMed    


  17. TALBOT BM, Jacko NF, Petit RA, Pegues DA, et al
    Unsuspected clonal spread of Methicillin-resistant Staphylococcus aureus causing bloodstream infections in hospitalized adults detected using whole genome sequencing.
    Clin Infect Dis. 2022 May 1. pii: 6576473. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  18. TAMMA PD, Aitken SL, Bonomo RA, Mathers AJ, et al
    Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum beta-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (
    Clin Infect Dis. 2022 Apr 19. pii: 6570801. doi: 10.1093.
    PubMed     Abstract available


  19. GRISKAITIS M, Furuya-Kanamori L, Allel K, Stabler R, et al
    beta-lactam resistant Streptococcus pneumoniae dynamics following treatment: a dose-response meta-analysis.
    Clin Infect Dis. 2022 Apr 19. pii: 6570668. doi: 10.1093.
    PubMed     Abstract available


  20. BARBEE LA, St Cyr SB
    Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guideli
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  21. FARZANA R, Jones LS, Rahman MA, Sands K, et al
    Genomic insights into the mechanism of carbapenem resistance dissemination in Enterobacterales from a tertiary public heath setting in South Asia.
    Clin Infect Dis. 2022 Apr 12. pii: 6567427. doi: 10.1093.
    PubMed     Abstract available


  22. ONG'UTI S, Czech M, Robilotti E, Holubar M, et al
    Cefiderocol: A New Cephalosporin Stratagem Against Multidrug-Resistant Gram-Negative Bacteria.
    Clin Infect Dis. 2022;74:1303-1312.
    PubMed     Abstract available


  23. PATEL R, Polage CR, Dien Bard J, May L, et al
    Envisioning Future Urinary Tract Infection Diagnostics.
    Clin Infect Dis. 2022;74:1284-1292.
    PubMed     Abstract available


    March 2022
  24. SHIVASABESAN G, Logan B, Brennan X, Lau C, et al
    Disseminated Aspergillus lentulus infection in a heart transplant recipient: a case report.
    Clin Infect Dis. 2022 Mar 11. pii: 6547270. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  25. HAYDEN FG, Asher J, Cowling BJ, Hurt AC, et al
    Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment.
    Clin Infect Dis. 2022;74:532-540.
    PubMed     Abstract available


  26. GHARPURE R, Friedman CR, Fialkowski V, Collins JP, et al
    Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community-Vermont, 2018.
    Clin Infect Dis. 2022;74:455-460.
    PubMed     Abstract available


  27. ZIEGLER MJ, Babcock HH, Welbel SF, Warren DK, et al
    Stopping Hospital Infections with Environmental Services (SHINE): A Cluster-Randomized Trial of Intensive Monitoring Methods for Terminal Room Cleaning on Rates of Multidrug-Resistant Organisms in the Intensive Care Unit.
    Clin Infect Dis. 2022 Feb 1. pii: 6518220. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  28. WESTON EJ, Heidenga BL, Farley MM, Tunali A, et al
    Surveillance for Disseminated Gonococcal Infections, Active Bacterial Core surveillance (ABCs) - United States, 2015-2019.
    Clin Infect Dis. 2022 Jan 28. pii: 6516834. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  29. BHATTARAI S, Sharma BK, Subedi N, Ranabhat S, et al
    Burden of Serious Bacterial Infections and Multidrug-Resistant Organisms in an Adult Population of Nepal: A Comparative Analysis of Minimally Invasive Tissue Sampling Informed Mortality Surveillance of Community and Hospital Deaths.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  30. STRELING AP, Al Obaidi MM, Lainhart WD, Zangeneh T, et al
    Evolution of Cefiderocol Non-Susceptibility in Pseudomonas aeruginosa in a Patient Without Previous Exposure to the Antibiotic.
    Clin Infect Dis. 2021;73:e4472-e4474.
    PubMed     Abstract available


  31. TAMMA PD, Beisken S, Bergman Y, Posch AE, et al
    Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance.
    Clin Infect Dis. 2021;73:e4599-e4606.
    PubMed     Abstract available


  32. KOURTIS AP, Sheriff EA, Weiner-Lastinger LM, Elmore K, et al
    Antibiotic Multidrug Resistance of Escherichia coli Causing Device- and Procedure-related Infections in the United States Reported to the National Healthcare Safety Network, 2013-2017.
    Clin Infect Dis. 2021;73:e4552-e4559.
    PubMed     Abstract available


  33. BHUTTA ZA
    International Travel and the Risk of Extensively Drug-resistant Typhoid: Issues and Potential Solutions.
    Clin Infect Dis. 2021;73:e4590-e4591.
    PubMed    


  34. KNOX J, Uhlemann AC, Lowy FD
    Stopping Household Methicillin-resistant Staphylococcusaureus Transmission and Recurrent Infections: An Unmet Challenge.
    Clin Infect Dis. 2021;73:e4578-e4580.
    PubMed    


  35. TAMMA PD, Aitken SL, Bonomo RA, Mathers AJ, et al
    Infectious Diseases Society of America Guidance on the Treatment of AmpC beta-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.
    Clin Infect Dis. 2021 Dec 5. pii: 6453394. doi: 10.1093/cid/ciab1013.
    PubMed     Abstract available


  36. AVERY RK, Alain S, Alexander BD, Blumberg EA, et al
    Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results from a Phase 3 Randomized Clinical Trial.
    Clin Infect Dis. 2021 Dec 2. pii: 6448443. doi: 10.1093.
    PubMed     Abstract available


  37. AFOLAYAN AO, Oaikhena AO, Aboderin AO, Olabisi OF, et al
    Clones and Clusters of Antimicrobial-Resistant Klebsiella From Southwestern Nigeria.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  38. KEKRE M, Arevalo SA, Valencia MF, Lagrada ML, et al
    Integrating Scalable Genome Sequencing Into Microbiology Laboratories for Routine Antimicrobial Resistance Surveillance.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  39. SAAVEDRA SY, Bernal JF, Montilla-Escudero E, Arevalo SA, et al
    Complexity of Genomic Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Isolates in Colombia Urges the Reinforcement of Whole Genome Sequencing-Based Surveillance Programs.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  40. NAGARAJ G, Shamanna V, Govindan V, Rose S, et al
    High-Resolution Genomic Profiling of Carbapenem-Resistant Klebsiella pneumoniae Isolates: A Multicentric Retrospective Indian Study.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  41. ABRUDAN M, Matimba A, Nikolic D, Hughes D, et al
    Train-the-Trainer as an Effective Approach to Building Global Networks of Experts in Genomic Surveillance of Antimicrobial Resistance (AMR).
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  42. AANENSEN DM, Carlos CC, Donado-Godoy P, Okeke IN, et al
    Implementing Whole-Genome Sequencing for Ongoing Surveillance of Antimicrobial Resistance: Exemplifying Insights Into Klebsiella pneumoniae.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  43. ARGIMON S, David S, Underwood A, Abrudan M, et al
    Rapid Genomic Characterization and Global Surveillance of Klebsiella Using Pathogenwatch.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


    November 2021
  44. MORTIMER TD, Pathela P, Crawley A, Rakeman JL, et al
    The Distribution and Spread of Susceptible and Resistant Neisseria gonorrhoeae Across Demographic Groups in a Major Metropolitan Center.
    Clin Infect Dis. 2021;73:e3146-e3155.
    PubMed     Abstract available


    October 2021
  45. ARGIMON S, Nagaraj G, Shamanna V, Darmavaram S, et al
    Circulation of third-generation cephalosporin resistant Salmonella Typhi in Mumbai, India.
    Clin Infect Dis. 2021 Oct 9. pii: 6385881. doi: 10.1093.
    PubMed     Abstract available


  46. FOWLER VG, Jezek A, Spivak ES, Talkington K, et al
    Urgent, Comprehensive Federal Action Needed To Stem Mortality and Medicare Costs Associated With Antimicrobial Resistance.
    Clin Infect Dis. 2021 Oct 7. pii: 6374435. doi: 10.1093.
    PubMed     Abstract available


  47. ARZIKA AM, Maliki R, Abdou A, Mankara AK, et al
    Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial.
    Clin Infect Dis. 2021;73:1292-1295.
    PubMed     Abstract available


  48. HACKETT S, Teasdale CA, Pals S, Muttiti A, et al
    Drug Resistance Mutations Among South African Children Living With HIV on WHO-recommended ART Regimens.
    Clin Infect Dis. 2021;73:e2217-e2225.
    PubMed     Abstract available


    September 2021
  49. KHATRI AM, Anderson AD, Camargo JF
    Addition Of Oral Fosfomycin To Antimicrobial Salvage Therapy For Persistent Vancomycin-Resistant Enterococcal Bacteremia.
    Clin Infect Dis. 2021 Sep 18. pii: 6372244. doi: 10.1093.
    PubMed    


  50. AVEDISSIAN SN, Scheetz MH, Cortes-Penfield N
    Early Switch From Vancomycin to Daptomycin in Methicillin-Resistant Staphylococcus aureus Bacteremia: Still More Questions Than Answers.
    Clin Infect Dis. 2021;73:1128-1129.
    PubMed    


  51. DIONNE B, Lee TC
    Probable Immortal Time Bias in Comparison of Daptomycin and Vancomycin for Methicillin-resistant Staphylococcus Aureus Bloodstream Infections.
    Clin Infect Dis. 2021;73:1127-1128.
    PubMed    


  52. HOLDERMAN JL, Thomas JC, Schlanger K, Black JM, et al
    Sustained Transmission of Neisseria gonorrhoeae with High-Level Resistance to Azithromycin, in Indianapolis, Indiana, 2017-2018.
    Clin Infect Dis. 2021;73:808-815.
    PubMed     Abstract available


    August 2021
  53. CURREN EJ, Lutgring JD, Kabbani S, Diekema DJ, et al
    Advancing Diagnostic Stewardship for Healthcare Associated Infections, Antibiotic Resistance, and Sepsis.
    Clin Infect Dis. 2021 Aug 4. pii: 6338696. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  54. KLAUSNER JD, Bristow CC, Soge OO, Shahkolahi A, et al
    Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.
    Clin Infect Dis. 2021;73:298-303.
    PubMed     Abstract available


  55. ANDRIANAIVOARIMANANA V, Wagner DM, Birdsell DN, Nikolay B, et al
    Transmission of antimicrobial resistant Yersinia pestis during a pneumonic plague outbreak.
    Clin Infect Dis. 2021 Jul 9. pii: 6318455. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  56. MCCLUNG RP, Oster AM, Ocfemia MCB, Saduvala N, et al
    Transmitted Drug Resistance Among HIV-1 Diagnoses in the United States, 2014-2018.
    Clin Infect Dis. 2021 Jun 27. pii: 6310273. doi: 10.1093.
    PubMed     Abstract available


  57. KAYE KS, Gupta V, Mulgirigama A, Joshi AV, et al
    Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011-2019: Rising ESBL Strains and Impact on Patient Management.
    Clin Infect Dis. 2021 Jun 18. pii: 6304915. doi: 10.1093.
    PubMed     Abstract available


  58. STEWART AG, Satlin MJ, Schlebusch S, Isler B, et al
    Completing the Picture-Capturing the Resistome in Antibiotic Clinical Trials.
    Clin Infect Dis. 2021;72:e1122-e1129.
    PubMed     Abstract available


  59. AL-HASAN MN
    Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target.
    Clin Infect Dis. 2021;72:2121-2123.
    PubMed    


  60. KARLOWSKY JA, Lob SH, Raddatz J, DePestel DD, et al
    In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United S
    Clin Infect Dis. 2021;72:2112-2120.
    PubMed     Abstract available


  61. KLEIN S, Boutin S, Kocer K, Fiedler MO, et al
    Rapid development of cefiderocol resistance in carbapenem-resistant Enterobacter cloacae during therapy is associated with heterogeneous mutations in the catecholate siderophore receptor cira.
    Clin Infect Dis. 2021 Jun 3. pii: 6291426. doi: 10.1093.
    PubMed     Abstract available


  62. AZARIAN T
    The Importance of Pathogen Whole-Genome Sequencing in Evaluating Interventions to Reduce the Spread of Multidrug-Resistant Organisms in the Healthcare Setting.
    Clin Infect Dis. 2021;72:1888-1890.
    PubMed    


  63. YAHAV D, Tau N, Shepshelovich D
    Assessment of Data Supporting the Efficacy of New Antibiotics for Treating Infections Caused by Multidrug-resistant Bacteria.
    Clin Infect Dis. 2021;72:1968-1974.
    PubMed     Abstract available


    May 2021
  64. WRIGHT WF, Jorgensen SCJ, Spellberg B
    Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and Guidelines.
    Clin Infect Dis. 2021;72:e682-e684.
    PubMed    


  65. HOUPT ER, Ferdous T, Ara R, Ibrahim M, et al
    Clinical Outcomes of Drug-resistant Shigellosis Treated With Azithromycin in Bangladesh.
    Clin Infect Dis. 2021;72:1793-1798.
    PubMed     Abstract available


  66. ROYER G, Clermont O, Condamine B, Mercier-Darty M, et al
    O-antigen targeted vaccines against E. coli may be useful in reducing morbidity, mortality and antimicrobial resistance.
    Clin Infect Dis. 2021 May 17. pii: 6277090. doi: 10.1093.
    PubMed    


  67. ROSE W, Fantl M, Geriak M, Nizet V, et al
    Current Paradigms of Combination therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination and For Which Patients?
    Clin Infect Dis. 2021 May 16. pii: 6276527. doi: 10.1093.
    PubMed     Abstract available


  68. WILSON GM, Suda KJ, Fitzpatrick MA, Bartle B, et al
    Risk Factors Associated with Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Positive Cultures in a Cohort of U.S. Veterans.
    Clin Infect Dis. 2021 May 11. pii: 6273455. doi: 10.1093.
    PubMed     Abstract available


  69. SATLIN MJ, Chen L, Douglass C, Hovan M, et al
    Colonization with Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
    Clin Infect Dis. 2021 May 6. pii: 6270940. doi: 10.1093.
    PubMed     Abstract available


  70. KARCHMER AW
    Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia: Beauty Remains in the Eye of the Beholder.
    Clin Infect Dis. 2021;72:1526-1528.
    PubMed    


    April 2021
  71. POTTS CC, Retchless AC, McNamara LA, Marasini D, et al
    Acquisition of ciprofloxacin resistance among an expanding clade of beta-lactamase positive, serogroup Y Neisseria meningitidis in the United States.
    Clin Infect Dis. 2021 Apr 26. pii: 6253703. doi: 10.1093.
    PubMed     Abstract available


  72. GHANI R, Mullish BH, McDonald JAK, Ghazy A, et al
    Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms.
    Clin Infect Dis. 2021;72:1444-1447.
    PubMed     Abstract available


  73. KHANNA S
    Microbiome-based Therapies for Multidrug-resistant Pathobionts: Getting a Step Closer!
    Clin Infect Dis. 2021;72:1448-1449.
    PubMed    


  74. TAMMA PD, Aitken SL, Bonomo RA, Mathers AJ, et al
    Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum beta-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P
    Clin Infect Dis. 2021;72:1109-1116.
    PubMed     Abstract available


    March 2021
  75. CAREY ME, Jain R, Yousuf M, Maes M, et al
    Spontaneous Emergence of Azithromycin Resistance in Independent Lineages of Salmonella Typhi in Northern India.
    Clin Infect Dis. 2021;72:e120-e127.
    PubMed     Abstract available


    February 2021
  76. STRICH JR, Ricotta E, Warner S, Lai YL, et al
    Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals.
    Clin Infect Dis. 2021;72:611-621.
    PubMed     Abstract available


  77. HARRIS PNA, Alexander M W
    Beyond the Core Genome: Tracking Plasmids in Outbreaks of Multidrug-resistant Bacteria.
    Clin Infect Dis. 2021;72:421-422.
    PubMed    


  78. DE MAN TJB, Yaffee AQ, Zhu W, Batra D, et al
    Multispecies Outbreak of Verona Integron-Encoded Metallo-ss-Lactamase-Producing Multidrug Resistant Bacteria Driven by a Promiscuous Incompatibility Group A/C2 Plasmid.
    Clin Infect Dis. 2021;72:414-420.
    PubMed     Abstract available


    January 2021
  79. TANNER WD, Leecaster MK, Zhang Y, Stratford KM, et al
    Environmental Contamination of Contact Precaution and Non-Contact Precaution Patient Rooms in Six Acute Care Facilities.
    Clin Infect Dis. 2021;72.
    PubMed     Abstract available


  80. NELSON RE, Hatfield KM, Wolford H, Samore MH, et al
    National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States.
    Clin Infect Dis. 2021;72.
    PubMed     Abstract available


  81. LIPWORTH S, Vihta KD, Chau KK, Kavanagh J, et al
    Ten years of population-level genomic Escherichia coli and Klebsiella pneumoniae serotype surveillance informs vaccine development for invasive infections.
    Clin Infect Dis. 2021 Jan 7. pii: 6067638. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  82. KENDALL EA, Kitonsa PJ, Nalutaaya A, Kamoga CE, et al
    The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities.
    Clin Infect Dis. 2020 Dec 6. pii: 6024999. doi: 10.1093/cid/ciaa1824.
    PubMed     Abstract available


    November 2020
  83. WILSON BM, Jiang Y, Jump RLP, Colindres RV, et al
    Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance.
    Clin Infect Dis. 2020 Nov 27. pii: 6007573. doi: 10.1093/cid/ciaa1769.
    PubMed     Abstract available


  84. IMLAY HN, Kaul DR
    Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients.
    Clin Infect Dis. 2020 Nov 17. pii: 5983750. doi: 10.1093/cid/ciaa1713.
    PubMed     Abstract available


    October 2020
  85. PYNGOTTU A, Scherrer AU, Kouyos R, Huber M, et al
    Predictors of virological failure and time to viral suppression of first line integrase inhibitor based antiretroviral treatment.
    Clin Infect Dis. 2020 Oct 24. pii: 5937176. doi: 10.1093/cid/ciaa1614.
    PubMed     Abstract available


    August 2020
  86. CROWELL TA, Danboise B, Parikh A, Esber A, et al
    Pre-Treatment and Acquired Antiretroviral Drug Resistance among Persons Living with HIV in Four African Countries.
    Clin Infect Dis. 2020 Aug 12. pii: 5891786. doi: 10.1093/cid/ciaa1161.
    PubMed     Abstract available


    June 2020
  87. CHOI SH, Dagher M, Ruffin F, Park LP, et al
    Risk Factors for Recurrent Staphylococcus aureus Bacteremia.
    Clin Infect Dis. 2020 Jun 21. pii: 5860449. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  88. SULTAN AS, Vila T, Montelongo-Jauregui D, Jabra-Rizk MA, et al
    The Global Emergence of the Fungal Pathogen Candida auris.
    Clin Infect Dis. 2020 May 18. pii: 5838782. doi: 10.1093.
    PubMed    


  89. DOOKIE N, Padayatchi N, Lessells RJ, Naicker CL, et al
    Individualised treatment of Multi-Drug Resistant Tuberculosis using Whole Genome Sequencing and Expanded Drug Susceptibility Testing.
    Clin Infect Dis. 2020 May 8. pii: 5834727. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  90. GORWOOD J, Bourgeois C, Pourcher V, Pourcher G, et al
    The integrase inhibitors dolutegravir and raltegravir exert pro-adipogenic and profibrotic effects and induce insulin resistance in human/simian adipose tissue and human adipocytes.
    Clin Infect Dis. 2020 Mar 13. pii: 5804258. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  91. MCGEE L, Chochua S, Li Z, Mathis S, et al
    Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015-2017.
    Clin Infect Dis. 2020 Feb 15. pii: 5736375. doi: 10.1093.
    PubMed     Abstract available


  92. POPPING S, Verwijs R, Cuypers L, Claassen M, et al
    Transmission of NS5A resistance associated substitutions among men-who-have-sex-with-men recently infected with hepatitis C virus genotype 1a.
    Clin Infect Dis. 2020 Feb 14. pii: 5735665. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  93. WALLIS CL, Hughes MD, Ritz J, Viana R, et al
    Diverse HIV-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line ART in Resource Limited Settings.
    Clin Infect Dis. 2019 Nov 14. pii: 5625392. doi: 10.1093/cid/ciz1116.
    PubMed     Abstract available


    September 2019
  94. SHAH M, Paradis S, Betz J, Beylis N, et al
    Multicenter Study of the Accuracy of the BD MAX MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid.
    Clin Infect Dis. 2019 Sep 27. pii: 5574845. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: